Der Einfluss von Glukokortikoiden bei der Therapie des Hörsturzes

Beside blood flow promoting drugs the treatment of sensorineural hearing loss (SNHL) consists of the application of glucocorticoids. The aim of the present study was to investigate the influence of glucocorticoids in the treatment of SNHL. We analysed therefore retrospectively the pre- and posttherapeutic audiograms of 603 patients with SNHL. 301 patients received intravenous therapy with blood flow promoting drugs without glucocorticoids and 302 patients with glucocorticoids. Patients with SNHL in the lower and middle frequencies who received glucocorticoids, showed significantly better recovery of hearing levels compared with the patient group without glucocorticoids. At higher frequencies there was no significant difference. Copyright (C) 2000 S. Karger AG,Basel.